PH Form 144: Insider to Sell 3,750 Shares via UBS on NYSE

Rhea-AI Filing Summary

Parker-Hannifin (PH) filed a Form 144 notice reporting a proposed sale of 3,750 common shares through UBS Financial Services with an approximate aggregate market value of $2,815,919. The shares are scheduled for sale on 08/25/2025 on the NYSE. The filing shows the shares were acquired by the reporting person through RSU vesting: 1,472 shares vested on 04/27/2022 and 2,278 shares vested on 04/24/2025, with payment settled by wire. No sales by the reporting person in the past three months are reported and the filer certifies they are not aware of any undisclosed material adverse information.

Positive

• Full disclosure of acquisition dates and nature: Both RSU vesting events (04/27/2022 and 04/24/2025) are specified
• Broker and execution details provided: Sale to be executed through UBS Financial Services on the NYSE, supporting transparency
• No recent sales reported: "Nothing to Report" for securities sold during the past three months

Negative

• Size of proposed sale is non-trivial: Aggregate market value reported as $2,815,919 which some investors may view negatively

Insights

Securities Analyst

TL;DR: Insider plans to sell 3,750 shares (~$2.82M) acquired via RSU vesting; transaction follows Rule 144 procedures.

The filing documents a routine Rule 144 notice for the proposed sale of a modest number of shares by a person associated with Parker-Hannifin. The shares were acquired via RSU vesting in 2022 and 2025 and the sale will be executed through UBS on the NYSE. Because the filer reports no other sales in the past three months and the transaction is disclosed under Rule 144, this appears to be a compliance-driven sale rather than an undisclosed material event. The aggregate value is explicitly stated, enabling investors to quantify the size of the transaction.

Corporate Governance Expert

TL;DR: Disclosure aligns with required insider-sale procedures; RSU-origin of shares reduces questions about special purchases.

The notice provides clear acquisition provenance (RSU vesting) and broker details, which supports transparency and adherence to Rule 144 protocols. The signer also affirms no undisclosed material adverse information exists. From a governance perspective, the filing meets disclosure expectations for an insider sale, with no indications of procedural irregularities or planned circumventing of lock-up provisions in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3750	2815919	127778004	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2022	RSU Vesting	Parker Hannifin			1472	04/27/2022	Wire
Common	04/24/2025	RSU Vesting	Parker Hannifin			2278	04/24/2025	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Parker-Hannifin's (PH) Form 144 disclose?

The Form 144 discloses a proposed sale of 3,750 common shares through UBS with an aggregate market value of $2,815,919, to be sold on 08/25/2025 on the NYSE.

How were the shares being sold by the Parker-Hannifin insider acquired?

The filing states the shares were acquired via RSU vesting: 1,472 shares vested on 04/27/2022 and 2,278 shares vested on 04/24/2025.

Has the reporting person sold PH securities in the past three months?

No. The filing indicates "Nothing to Report" for securities sold during the past three months.

Through which broker will the Parker-Hannifin shares be sold?

The proposed sale is to be executed through UBS Financial Services Inc. located at the address listed in the filing.

Does the filer state any undisclosed material adverse information about PH?

By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.